Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
story of the week
Published in Neurology

Journal Scan / Commentary · January 28, 2021

Bioequivalence and Switchability of Generic Antiseizure Medications



Additional Info

Bioequivalence and Switchability of Generic Antiseizure Medications (ASMs): A Re-Appraisal Based on Analysis of Generic ASM Products Approved in Europe
Epilepsia 2021 Jan 10;[EPub Ahead of Print], R Odi, V Franco, E Perucca, M Bialer

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading